# A Study of MK-2060 in Healthy Participants (MK-2060-016)

> **NCT06582602** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 23 (actual)

## Conditions studied

- Venous Thrombosis

## Interventions

- **BIOLOGICAL:** MK-2060
- **BIOLOGICAL:** Placebo

## Key facts

- **NCT ID:** NCT06582602
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-10-15
- **Primary completion:** 2025-04-18
- **Final completion:** 2025-04-18
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2025-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06582602

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06582602, "A Study of MK-2060 in Healthy Participants (MK-2060-016)". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT06582602. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*